bioAffinity Technologies, Inc. (NASDAQ: BIAF) reported Q2 EPS of ($0.17), $0.07 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.3 million versus the consensus estimate of $1.21 million.

For earnings history and earnings-related data on bioAffinity Technologies, Inc. (BIAF) click here.